Journal of Stroke & Cerebrovascular Diseases-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=587043, encodeId=df1258e043bd, content=1月22投的，到3.19，两个月了还是under review，感觉比评论里慢好多哦，好怕被拒，有点慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVwJ30cBicvMqfUQVv9NaGZ57cSJmOTJIHzcF8iblnZf0icHcNF3aCLbS7vdlliaaibTeUyLiaQjyEuoiaQ/132, createdBy=695d5262554, createdName=樱花7802, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945566, encodeId=fe559455660d, content=请问投这个杂志meta分析，文章类型选什么啊，我在官网投稿看到Review Article(invitation only)是不是只有被邀请，才能投meta分析, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92992475559, createdName=1244896bm50暂无昵称, createdTime=Thu Mar 04 22:55:44 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096343, encodeId=b3f82096343d1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑血管疾病 经验分享：正在准备下一篇文章，再次用到这个系统决定写点经验回馈大家。临床小硕，一篇脑血管方面的文章。一审40天，审稿意见中肯严谨；按审稿意见修改15天后修回，20天后accept，差不多两个半月后online。研究生的第一篇文章，可以选择非OA不要版面费，现影响因子见长，目前2.667。加油吧医学僧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/d6e0b113f3f375444106bd57c5f62af3.jpg, createdBy=03155285285, createdName=V哈哈静, createdTime=Wed Oct 26 21:26:04 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147962, encodeId=fd48214e9626d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中;康复 经验分享：我师兄是雪落的誓言哈哈哈，我跟着他投的期刊。具体时间线：5月31日提交。6月02日 With Editor。6月05日 Under Review（邀请3，接受评审2）。6月26日RRC。6月26日 Major Revise（6条意见）。 7月07日提交修订，7月09日 With Editor，7月11日 Under Review（邀请1，接受评审1）。7月13日RRC。7月14日 Accept。一定要按照修改意见一条一条修改！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75f78245022, createdName=ms6000000472127135, createdTime=Fri Jul 14 08:24:54 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1231312, encodeId=f26612313122e, content=偏重的研究方向：房颤;心血管 经验分享：投稿后With Editor 4天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220708/c81f7dd923c54b8e84fe4716ff9fb706/a82b7266897b4d8c993cc7394b5d6767.jpg, createdBy=80462347615, createdName=122a44d6m85(暂无昵称), createdTime=Fri Jul 08 12:36:25 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892524, encodeId=69038925242c, content=写了篇蛛血预后指标的第二天就被拒了，说不符合他们期刊内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200926/f3a044b4994440679e9fbd0eb436f1c4/4f700d5927e040d591dc11f22ed068df.jpg, createdBy=88fa5263090, createdName=Timky, createdTime=Fri Oct 16 19:31:19 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217586, encodeId=296f121e586d5, content=投了一个月了还是外审，感觉慢多了？有最近投的战友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Sat May 07 11:24:53 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060833, encodeId=e0c1106083332, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：临床研究;脑血管疾病 经验分享：Sep 09, 2021 投稿，2周给回意见小修，2周修回，Oct 13, 2021接受，神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Fri Oct 15 19:49:12 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571817, encodeId=39005e181781, content=审稿速度:1.0 经验分享：脑卒中病例对照研究。5.21 开始under review，6.2收到拒稿通知，只有一个审稿人，认为样本量太少，关联存在偶然性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ee72530812, createdName=124ff737m56(暂无昵称), createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526443, encodeId=f4ab52644379, content=请问这个杂志接受脑血管病的实验文章不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac31694476, createdName=1de67449m99(暂无匿称), createdTime=Mon Aug 29 00:54:00 CST 2016, time=2016-08-29, status=1, ipAttribution=)]

2020-03-20 樱花7802

1月22投的，到3.19，两个月了还是under review，感觉比评论里慢好多哦，好怕被拒，有点慌

162 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=587043, encodeId=df1258e043bd, content=1月22投的，到3.19，两个月了还是under review，感觉比评论里慢好多哦，好怕被拒，有点慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVwJ30cBicvMqfUQVv9NaGZ57cSJmOTJIHzcF8iblnZf0icHcNF3aCLbS7vdlliaaibTeUyLiaQjyEuoiaQ/132, createdBy=695d5262554, createdName=樱花7802, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945566, encodeId=fe559455660d, content=请问投这个杂志meta分析，文章类型选什么啊，我在官网投稿看到Review Article(invitation only)是不是只有被邀请，才能投meta分析, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92992475559, createdName=1244896bm50暂无昵称, createdTime=Thu Mar 04 22:55:44 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096343, encodeId=b3f82096343d1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑血管疾病 经验分享：正在准备下一篇文章，再次用到这个系统决定写点经验回馈大家。临床小硕，一篇脑血管方面的文章。一审40天，审稿意见中肯严谨；按审稿意见修改15天后修回，20天后accept，差不多两个半月后online。研究生的第一篇文章，可以选择非OA不要版面费，现影响因子见长，目前2.667。加油吧医学僧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/d6e0b113f3f375444106bd57c5f62af3.jpg, createdBy=03155285285, createdName=V哈哈静, createdTime=Wed Oct 26 21:26:04 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147962, encodeId=fd48214e9626d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中;康复 经验分享：我师兄是雪落的誓言哈哈哈，我跟着他投的期刊。具体时间线：5月31日提交。6月02日 With Editor。6月05日 Under Review（邀请3，接受评审2）。6月26日RRC。6月26日 Major Revise（6条意见）。 7月07日提交修订，7月09日 With Editor，7月11日 Under Review（邀请1，接受评审1）。7月13日RRC。7月14日 Accept。一定要按照修改意见一条一条修改！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75f78245022, createdName=ms6000000472127135, createdTime=Fri Jul 14 08:24:54 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1231312, encodeId=f26612313122e, content=偏重的研究方向：房颤;心血管 经验分享：投稿后With Editor 4天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220708/c81f7dd923c54b8e84fe4716ff9fb706/a82b7266897b4d8c993cc7394b5d6767.jpg, createdBy=80462347615, createdName=122a44d6m85(暂无昵称), createdTime=Fri Jul 08 12:36:25 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892524, encodeId=69038925242c, content=写了篇蛛血预后指标的第二天就被拒了，说不符合他们期刊内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200926/f3a044b4994440679e9fbd0eb436f1c4/4f700d5927e040d591dc11f22ed068df.jpg, createdBy=88fa5263090, createdName=Timky, createdTime=Fri Oct 16 19:31:19 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217586, encodeId=296f121e586d5, content=投了一个月了还是外审，感觉慢多了？有最近投的战友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Sat May 07 11:24:53 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060833, encodeId=e0c1106083332, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：临床研究;脑血管疾病 经验分享：Sep 09, 2021 投稿，2周给回意见小修，2周修回，Oct 13, 2021接受，神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Fri Oct 15 19:49:12 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571817, encodeId=39005e181781, content=审稿速度:1.0 经验分享：脑卒中病例对照研究。5.21 开始under review，6.2收到拒稿通知，只有一个审稿人，认为样本量太少，关联存在偶然性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ee72530812, createdName=124ff737m56(暂无昵称), createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526443, encodeId=f4ab52644379, content=请问这个杂志接受脑血管病的实验文章不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac31694476, createdName=1de67449m99(暂无匿称), createdTime=Mon Aug 29 00:54:00 CST 2016, time=2016-08-29, status=1, ipAttribution=)]

2021-03-04 1244896bm50暂无昵称

请问投这个杂志meta分析，文章类型选什么啊，我在官网投稿看到Review Article(invitation only)是不是只有被邀请，才能投meta分析

88 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=587043, encodeId=df1258e043bd, content=1月22投的，到3.19，两个月了还是under review，感觉比评论里慢好多哦，好怕被拒，有点慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVwJ30cBicvMqfUQVv9NaGZ57cSJmOTJIHzcF8iblnZf0icHcNF3aCLbS7vdlliaaibTeUyLiaQjyEuoiaQ/132, createdBy=695d5262554, createdName=樱花7802, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945566, encodeId=fe559455660d, content=请问投这个杂志meta分析，文章类型选什么啊，我在官网投稿看到Review Article(invitation only)是不是只有被邀请，才能投meta分析, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92992475559, createdName=1244896bm50暂无昵称, createdTime=Thu Mar 04 22:55:44 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096343, encodeId=b3f82096343d1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑血管疾病 经验分享：正在准备下一篇文章，再次用到这个系统决定写点经验回馈大家。临床小硕，一篇脑血管方面的文章。一审40天，审稿意见中肯严谨；按审稿意见修改15天后修回，20天后accept，差不多两个半月后online。研究生的第一篇文章，可以选择非OA不要版面费，现影响因子见长，目前2.667。加油吧医学僧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/d6e0b113f3f375444106bd57c5f62af3.jpg, createdBy=03155285285, createdName=V哈哈静, createdTime=Wed Oct 26 21:26:04 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147962, encodeId=fd48214e9626d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中;康复 经验分享：我师兄是雪落的誓言哈哈哈，我跟着他投的期刊。具体时间线：5月31日提交。6月02日 With Editor。6月05日 Under Review（邀请3，接受评审2）。6月26日RRC。6月26日 Major Revise（6条意见）。 7月07日提交修订，7月09日 With Editor，7月11日 Under Review（邀请1，接受评审1）。7月13日RRC。7月14日 Accept。一定要按照修改意见一条一条修改！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75f78245022, createdName=ms6000000472127135, createdTime=Fri Jul 14 08:24:54 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1231312, encodeId=f26612313122e, content=偏重的研究方向：房颤;心血管 经验分享：投稿后With Editor 4天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220708/c81f7dd923c54b8e84fe4716ff9fb706/a82b7266897b4d8c993cc7394b5d6767.jpg, createdBy=80462347615, createdName=122a44d6m85(暂无昵称), createdTime=Fri Jul 08 12:36:25 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892524, encodeId=69038925242c, content=写了篇蛛血预后指标的第二天就被拒了，说不符合他们期刊内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200926/f3a044b4994440679e9fbd0eb436f1c4/4f700d5927e040d591dc11f22ed068df.jpg, createdBy=88fa5263090, createdName=Timky, createdTime=Fri Oct 16 19:31:19 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217586, encodeId=296f121e586d5, content=投了一个月了还是外审，感觉慢多了？有最近投的战友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Sat May 07 11:24:53 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060833, encodeId=e0c1106083332, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：临床研究;脑血管疾病 经验分享：Sep 09, 2021 投稿，2周给回意见小修，2周修回，Oct 13, 2021接受，神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Fri Oct 15 19:49:12 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571817, encodeId=39005e181781, content=审稿速度:1.0 经验分享：脑卒中病例对照研究。5.21 开始under review，6.2收到拒稿通知，只有一个审稿人，认为样本量太少，关联存在偶然性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ee72530812, createdName=124ff737m56(暂无昵称), createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526443, encodeId=f4ab52644379, content=请问这个杂志接受脑血管病的实验文章不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac31694476, createdName=1de67449m99(暂无匿称), createdTime=Mon Aug 29 00:54:00 CST 2016, time=2016-08-29, status=1, ipAttribution=)]

2022-10-26 V哈哈静

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：脑血管疾病
经验分享：正在准备下一篇文章，再次用到这个系统决定写点经验回馈大家。临床小硕，一篇脑血管方面的文章。一审40天，审稿意见中肯严谨；按审稿意见修改15天后修回，20天后accept，差不多两个半月后online。研究生的第一篇文章，可以选择非OA不要版面费，现影响因子见长，目前2.667。加油吧医学僧！

70 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=587043, encodeId=df1258e043bd, content=1月22投的，到3.19，两个月了还是under review，感觉比评论里慢好多哦，好怕被拒，有点慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVwJ30cBicvMqfUQVv9NaGZ57cSJmOTJIHzcF8iblnZf0icHcNF3aCLbS7vdlliaaibTeUyLiaQjyEuoiaQ/132, createdBy=695d5262554, createdName=樱花7802, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945566, encodeId=fe559455660d, content=请问投这个杂志meta分析，文章类型选什么啊，我在官网投稿看到Review Article(invitation only)是不是只有被邀请，才能投meta分析, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92992475559, createdName=1244896bm50暂无昵称, createdTime=Thu Mar 04 22:55:44 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096343, encodeId=b3f82096343d1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑血管疾病 经验分享：正在准备下一篇文章，再次用到这个系统决定写点经验回馈大家。临床小硕，一篇脑血管方面的文章。一审40天，审稿意见中肯严谨；按审稿意见修改15天后修回，20天后accept，差不多两个半月后online。研究生的第一篇文章，可以选择非OA不要版面费，现影响因子见长，目前2.667。加油吧医学僧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/d6e0b113f3f375444106bd57c5f62af3.jpg, createdBy=03155285285, createdName=V哈哈静, createdTime=Wed Oct 26 21:26:04 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147962, encodeId=fd48214e9626d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中;康复 经验分享：我师兄是雪落的誓言哈哈哈，我跟着他投的期刊。具体时间线：5月31日提交。6月02日 With Editor。6月05日 Under Review（邀请3，接受评审2）。6月26日RRC。6月26日 Major Revise（6条意见）。 7月07日提交修订，7月09日 With Editor，7月11日 Under Review（邀请1，接受评审1）。7月13日RRC。7月14日 Accept。一定要按照修改意见一条一条修改！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75f78245022, createdName=ms6000000472127135, createdTime=Fri Jul 14 08:24:54 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1231312, encodeId=f26612313122e, content=偏重的研究方向：房颤;心血管 经验分享：投稿后With Editor 4天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220708/c81f7dd923c54b8e84fe4716ff9fb706/a82b7266897b4d8c993cc7394b5d6767.jpg, createdBy=80462347615, createdName=122a44d6m85(暂无昵称), createdTime=Fri Jul 08 12:36:25 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892524, encodeId=69038925242c, content=写了篇蛛血预后指标的第二天就被拒了，说不符合他们期刊内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200926/f3a044b4994440679e9fbd0eb436f1c4/4f700d5927e040d591dc11f22ed068df.jpg, createdBy=88fa5263090, createdName=Timky, createdTime=Fri Oct 16 19:31:19 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217586, encodeId=296f121e586d5, content=投了一个月了还是外审，感觉慢多了？有最近投的战友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Sat May 07 11:24:53 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060833, encodeId=e0c1106083332, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：临床研究;脑血管疾病 经验分享：Sep 09, 2021 投稿，2周给回意见小修，2周修回，Oct 13, 2021接受，神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Fri Oct 15 19:49:12 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571817, encodeId=39005e181781, content=审稿速度:1.0 经验分享：脑卒中病例对照研究。5.21 开始under review，6.2收到拒稿通知，只有一个审稿人，认为样本量太少，关联存在偶然性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ee72530812, createdName=124ff737m56(暂无昵称), createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526443, encodeId=f4ab52644379, content=请问这个杂志接受脑血管病的实验文章不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac31694476, createdName=1de67449m99(暂无匿称), createdTime=Mon Aug 29 00:54:00 CST 2016, time=2016-08-29, status=1, ipAttribution=)]

2023-07-14 ms6000000472127135 来自广东省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：脑卒中;康复
经验分享：我师兄是雪落的誓言哈哈哈，我跟着他投的期刊。具体时间线：5月31日提交。6月02日 With Editor。6月05日 Under Review（邀请3，接受评审2）。6月26日RRC。6月26日 Major Revise（6条意见）。 7月07日提交修订，7月09日 With Editor，7月11日 Under Review（邀请1，接受评审1）。7月13日RRC。7月14日 Accept。一定要按照修改意见一条一条修改！！！

42 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=587043, encodeId=df1258e043bd, content=1月22投的，到3.19，两个月了还是under review，感觉比评论里慢好多哦，好怕被拒，有点慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVwJ30cBicvMqfUQVv9NaGZ57cSJmOTJIHzcF8iblnZf0icHcNF3aCLbS7vdlliaaibTeUyLiaQjyEuoiaQ/132, createdBy=695d5262554, createdName=樱花7802, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945566, encodeId=fe559455660d, content=请问投这个杂志meta分析，文章类型选什么啊，我在官网投稿看到Review Article(invitation only)是不是只有被邀请，才能投meta分析, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92992475559, createdName=1244896bm50暂无昵称, createdTime=Thu Mar 04 22:55:44 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096343, encodeId=b3f82096343d1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑血管疾病 经验分享：正在准备下一篇文章，再次用到这个系统决定写点经验回馈大家。临床小硕，一篇脑血管方面的文章。一审40天，审稿意见中肯严谨；按审稿意见修改15天后修回，20天后accept，差不多两个半月后online。研究生的第一篇文章，可以选择非OA不要版面费，现影响因子见长，目前2.667。加油吧医学僧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/d6e0b113f3f375444106bd57c5f62af3.jpg, createdBy=03155285285, createdName=V哈哈静, createdTime=Wed Oct 26 21:26:04 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147962, encodeId=fd48214e9626d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中;康复 经验分享：我师兄是雪落的誓言哈哈哈，我跟着他投的期刊。具体时间线：5月31日提交。6月02日 With Editor。6月05日 Under Review（邀请3，接受评审2）。6月26日RRC。6月26日 Major Revise（6条意见）。 7月07日提交修订，7月09日 With Editor，7月11日 Under Review（邀请1，接受评审1）。7月13日RRC。7月14日 Accept。一定要按照修改意见一条一条修改！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75f78245022, createdName=ms6000000472127135, createdTime=Fri Jul 14 08:24:54 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1231312, encodeId=f26612313122e, content=偏重的研究方向：房颤;心血管 经验分享：投稿后With Editor 4天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220708/c81f7dd923c54b8e84fe4716ff9fb706/a82b7266897b4d8c993cc7394b5d6767.jpg, createdBy=80462347615, createdName=122a44d6m85(暂无昵称), createdTime=Fri Jul 08 12:36:25 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892524, encodeId=69038925242c, content=写了篇蛛血预后指标的第二天就被拒了，说不符合他们期刊内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200926/f3a044b4994440679e9fbd0eb436f1c4/4f700d5927e040d591dc11f22ed068df.jpg, createdBy=88fa5263090, createdName=Timky, createdTime=Fri Oct 16 19:31:19 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217586, encodeId=296f121e586d5, content=投了一个月了还是外审，感觉慢多了？有最近投的战友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Sat May 07 11:24:53 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060833, encodeId=e0c1106083332, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：临床研究;脑血管疾病 经验分享：Sep 09, 2021 投稿，2周给回意见小修，2周修回，Oct 13, 2021接受，神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Fri Oct 15 19:49:12 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571817, encodeId=39005e181781, content=审稿速度:1.0 经验分享：脑卒中病例对照研究。5.21 开始under review，6.2收到拒稿通知，只有一个审稿人，认为样本量太少，关联存在偶然性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ee72530812, createdName=124ff737m56(暂无昵称), createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526443, encodeId=f4ab52644379, content=请问这个杂志接受脑血管病的实验文章不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac31694476, createdName=1de67449m99(暂无匿称), createdTime=Mon Aug 29 00:54:00 CST 2016, time=2016-08-29, status=1, ipAttribution=)]

2022-07-08 122a44d6m85(暂无昵称)

偏重的研究方向：房颤;心血管
经验分享：投稿后With Editor 4天了

54 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=587043, encodeId=df1258e043bd, content=1月22投的，到3.19，两个月了还是under review，感觉比评论里慢好多哦，好怕被拒，有点慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVwJ30cBicvMqfUQVv9NaGZ57cSJmOTJIHzcF8iblnZf0icHcNF3aCLbS7vdlliaaibTeUyLiaQjyEuoiaQ/132, createdBy=695d5262554, createdName=樱花7802, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945566, encodeId=fe559455660d, content=请问投这个杂志meta分析，文章类型选什么啊，我在官网投稿看到Review Article(invitation only)是不是只有被邀请，才能投meta分析, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92992475559, createdName=1244896bm50暂无昵称, createdTime=Thu Mar 04 22:55:44 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096343, encodeId=b3f82096343d1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑血管疾病 经验分享：正在准备下一篇文章，再次用到这个系统决定写点经验回馈大家。临床小硕，一篇脑血管方面的文章。一审40天，审稿意见中肯严谨；按审稿意见修改15天后修回，20天后accept，差不多两个半月后online。研究生的第一篇文章，可以选择非OA不要版面费，现影响因子见长，目前2.667。加油吧医学僧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/d6e0b113f3f375444106bd57c5f62af3.jpg, createdBy=03155285285, createdName=V哈哈静, createdTime=Wed Oct 26 21:26:04 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147962, encodeId=fd48214e9626d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中;康复 经验分享：我师兄是雪落的誓言哈哈哈，我跟着他投的期刊。具体时间线：5月31日提交。6月02日 With Editor。6月05日 Under Review（邀请3，接受评审2）。6月26日RRC。6月26日 Major Revise（6条意见）。 7月07日提交修订，7月09日 With Editor，7月11日 Under Review（邀请1，接受评审1）。7月13日RRC。7月14日 Accept。一定要按照修改意见一条一条修改！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75f78245022, createdName=ms6000000472127135, createdTime=Fri Jul 14 08:24:54 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1231312, encodeId=f26612313122e, content=偏重的研究方向：房颤;心血管 经验分享：投稿后With Editor 4天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220708/c81f7dd923c54b8e84fe4716ff9fb706/a82b7266897b4d8c993cc7394b5d6767.jpg, createdBy=80462347615, createdName=122a44d6m85(暂无昵称), createdTime=Fri Jul 08 12:36:25 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892524, encodeId=69038925242c, content=写了篇蛛血预后指标的第二天就被拒了，说不符合他们期刊内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200926/f3a044b4994440679e9fbd0eb436f1c4/4f700d5927e040d591dc11f22ed068df.jpg, createdBy=88fa5263090, createdName=Timky, createdTime=Fri Oct 16 19:31:19 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217586, encodeId=296f121e586d5, content=投了一个月了还是外审，感觉慢多了？有最近投的战友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Sat May 07 11:24:53 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060833, encodeId=e0c1106083332, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：临床研究;脑血管疾病 经验分享：Sep 09, 2021 投稿，2周给回意见小修，2周修回，Oct 13, 2021接受，神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Fri Oct 15 19:49:12 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571817, encodeId=39005e181781, content=审稿速度:1.0 经验分享：脑卒中病例对照研究。5.21 开始under review，6.2收到拒稿通知，只有一个审稿人，认为样本量太少，关联存在偶然性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ee72530812, createdName=124ff737m56(暂无昵称), createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526443, encodeId=f4ab52644379, content=请问这个杂志接受脑血管病的实验文章不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac31694476, createdName=1de67449m99(暂无匿称), createdTime=Mon Aug 29 00:54:00 CST 2016, time=2016-08-29, status=1, ipAttribution=)]

2020-10-16 Timky

写了篇蛛血预后指标的第二天就被拒了，说不符合他们期刊内容

109 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=587043, encodeId=df1258e043bd, content=1月22投的，到3.19，两个月了还是under review，感觉比评论里慢好多哦，好怕被拒，有点慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVwJ30cBicvMqfUQVv9NaGZ57cSJmOTJIHzcF8iblnZf0icHcNF3aCLbS7vdlliaaibTeUyLiaQjyEuoiaQ/132, createdBy=695d5262554, createdName=樱花7802, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945566, encodeId=fe559455660d, content=请问投这个杂志meta分析，文章类型选什么啊，我在官网投稿看到Review Article(invitation only)是不是只有被邀请，才能投meta分析, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92992475559, createdName=1244896bm50暂无昵称, createdTime=Thu Mar 04 22:55:44 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096343, encodeId=b3f82096343d1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑血管疾病 经验分享：正在准备下一篇文章，再次用到这个系统决定写点经验回馈大家。临床小硕，一篇脑血管方面的文章。一审40天，审稿意见中肯严谨；按审稿意见修改15天后修回，20天后accept，差不多两个半月后online。研究生的第一篇文章，可以选择非OA不要版面费，现影响因子见长，目前2.667。加油吧医学僧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/d6e0b113f3f375444106bd57c5f62af3.jpg, createdBy=03155285285, createdName=V哈哈静, createdTime=Wed Oct 26 21:26:04 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147962, encodeId=fd48214e9626d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中;康复 经验分享：我师兄是雪落的誓言哈哈哈，我跟着他投的期刊。具体时间线：5月31日提交。6月02日 With Editor。6月05日 Under Review（邀请3，接受评审2）。6月26日RRC。6月26日 Major Revise（6条意见）。 7月07日提交修订，7月09日 With Editor，7月11日 Under Review（邀请1，接受评审1）。7月13日RRC。7月14日 Accept。一定要按照修改意见一条一条修改！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75f78245022, createdName=ms6000000472127135, createdTime=Fri Jul 14 08:24:54 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1231312, encodeId=f26612313122e, content=偏重的研究方向：房颤;心血管 经验分享：投稿后With Editor 4天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220708/c81f7dd923c54b8e84fe4716ff9fb706/a82b7266897b4d8c993cc7394b5d6767.jpg, createdBy=80462347615, createdName=122a44d6m85(暂无昵称), createdTime=Fri Jul 08 12:36:25 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892524, encodeId=69038925242c, content=写了篇蛛血预后指标的第二天就被拒了，说不符合他们期刊内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200926/f3a044b4994440679e9fbd0eb436f1c4/4f700d5927e040d591dc11f22ed068df.jpg, createdBy=88fa5263090, createdName=Timky, createdTime=Fri Oct 16 19:31:19 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217586, encodeId=296f121e586d5, content=投了一个月了还是外审，感觉慢多了？有最近投的战友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Sat May 07 11:24:53 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060833, encodeId=e0c1106083332, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：临床研究;脑血管疾病 经验分享：Sep 09, 2021 投稿，2周给回意见小修，2周修回，Oct 13, 2021接受，神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Fri Oct 15 19:49:12 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571817, encodeId=39005e181781, content=审稿速度:1.0 经验分享：脑卒中病例对照研究。5.21 开始under review，6.2收到拒稿通知，只有一个审稿人，认为样本量太少，关联存在偶然性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ee72530812, createdName=124ff737m56(暂无昵称), createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526443, encodeId=f4ab52644379, content=请问这个杂志接受脑血管病的实验文章不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac31694476, createdName=1de67449m99(暂无匿称), createdTime=Mon Aug 29 00:54:00 CST 2016, time=2016-08-29, status=1, ipAttribution=)]

2022-05-07 阿杰11

投了一个月了还是外审，感觉慢多了？有最近投的战友吗？

54 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=587043, encodeId=df1258e043bd, content=1月22投的，到3.19，两个月了还是under review，感觉比评论里慢好多哦，好怕被拒，有点慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVwJ30cBicvMqfUQVv9NaGZ57cSJmOTJIHzcF8iblnZf0icHcNF3aCLbS7vdlliaaibTeUyLiaQjyEuoiaQ/132, createdBy=695d5262554, createdName=樱花7802, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945566, encodeId=fe559455660d, content=请问投这个杂志meta分析，文章类型选什么啊，我在官网投稿看到Review Article(invitation only)是不是只有被邀请，才能投meta分析, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92992475559, createdName=1244896bm50暂无昵称, createdTime=Thu Mar 04 22:55:44 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096343, encodeId=b3f82096343d1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑血管疾病 经验分享：正在准备下一篇文章，再次用到这个系统决定写点经验回馈大家。临床小硕，一篇脑血管方面的文章。一审40天，审稿意见中肯严谨；按审稿意见修改15天后修回，20天后accept，差不多两个半月后online。研究生的第一篇文章，可以选择非OA不要版面费，现影响因子见长，目前2.667。加油吧医学僧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/d6e0b113f3f375444106bd57c5f62af3.jpg, createdBy=03155285285, createdName=V哈哈静, createdTime=Wed Oct 26 21:26:04 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147962, encodeId=fd48214e9626d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中;康复 经验分享：我师兄是雪落的誓言哈哈哈，我跟着他投的期刊。具体时间线：5月31日提交。6月02日 With Editor。6月05日 Under Review（邀请3，接受评审2）。6月26日RRC。6月26日 Major Revise（6条意见）。 7月07日提交修订，7月09日 With Editor，7月11日 Under Review（邀请1，接受评审1）。7月13日RRC。7月14日 Accept。一定要按照修改意见一条一条修改！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75f78245022, createdName=ms6000000472127135, createdTime=Fri Jul 14 08:24:54 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1231312, encodeId=f26612313122e, content=偏重的研究方向：房颤;心血管 经验分享：投稿后With Editor 4天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220708/c81f7dd923c54b8e84fe4716ff9fb706/a82b7266897b4d8c993cc7394b5d6767.jpg, createdBy=80462347615, createdName=122a44d6m85(暂无昵称), createdTime=Fri Jul 08 12:36:25 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892524, encodeId=69038925242c, content=写了篇蛛血预后指标的第二天就被拒了，说不符合他们期刊内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200926/f3a044b4994440679e9fbd0eb436f1c4/4f700d5927e040d591dc11f22ed068df.jpg, createdBy=88fa5263090, createdName=Timky, createdTime=Fri Oct 16 19:31:19 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217586, encodeId=296f121e586d5, content=投了一个月了还是外审，感觉慢多了？有最近投的战友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Sat May 07 11:24:53 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060833, encodeId=e0c1106083332, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：临床研究;脑血管疾病 经验分享：Sep 09, 2021 投稿，2周给回意见小修，2周修回，Oct 13, 2021接受，神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Fri Oct 15 19:49:12 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571817, encodeId=39005e181781, content=审稿速度:1.0 经验分享：脑卒中病例对照研究。5.21 开始under review，6.2收到拒稿通知，只有一个审稿人，认为样本量太少，关联存在偶然性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ee72530812, createdName=124ff737m56(暂无昵称), createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526443, encodeId=f4ab52644379, content=请问这个杂志接受脑血管病的实验文章不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac31694476, createdName=1de67449m99(暂无匿称), createdTime=Mon Aug 29 00:54:00 CST 2016, time=2016-08-29, status=1, ipAttribution=)]

2021-10-15 ms8000001327218017

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：临床研究;脑血管疾病
经验分享：Sep 09, 2021 投稿，2周给回意见小修，2周修回，Oct 13, 2021接受，神速。

61 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=587043, encodeId=df1258e043bd, content=1月22投的，到3.19，两个月了还是under review，感觉比评论里慢好多哦，好怕被拒，有点慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVwJ30cBicvMqfUQVv9NaGZ57cSJmOTJIHzcF8iblnZf0icHcNF3aCLbS7vdlliaaibTeUyLiaQjyEuoiaQ/132, createdBy=695d5262554, createdName=樱花7802, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945566, encodeId=fe559455660d, content=请问投这个杂志meta分析，文章类型选什么啊，我在官网投稿看到Review Article(invitation only)是不是只有被邀请，才能投meta分析, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92992475559, createdName=1244896bm50暂无昵称, createdTime=Thu Mar 04 22:55:44 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096343, encodeId=b3f82096343d1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑血管疾病 经验分享：正在准备下一篇文章，再次用到这个系统决定写点经验回馈大家。临床小硕，一篇脑血管方面的文章。一审40天，审稿意见中肯严谨；按审稿意见修改15天后修回，20天后accept，差不多两个半月后online。研究生的第一篇文章，可以选择非OA不要版面费，现影响因子见长，目前2.667。加油吧医学僧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/d6e0b113f3f375444106bd57c5f62af3.jpg, createdBy=03155285285, createdName=V哈哈静, createdTime=Wed Oct 26 21:26:04 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147962, encodeId=fd48214e9626d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中;康复 经验分享：我师兄是雪落的誓言哈哈哈，我跟着他投的期刊。具体时间线：5月31日提交。6月02日 With Editor。6月05日 Under Review（邀请3，接受评审2）。6月26日RRC。6月26日 Major Revise（6条意见）。 7月07日提交修订，7月09日 With Editor，7月11日 Under Review（邀请1，接受评审1）。7月13日RRC。7月14日 Accept。一定要按照修改意见一条一条修改！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75f78245022, createdName=ms6000000472127135, createdTime=Fri Jul 14 08:24:54 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1231312, encodeId=f26612313122e, content=偏重的研究方向：房颤;心血管 经验分享：投稿后With Editor 4天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220708/c81f7dd923c54b8e84fe4716ff9fb706/a82b7266897b4d8c993cc7394b5d6767.jpg, createdBy=80462347615, createdName=122a44d6m85(暂无昵称), createdTime=Fri Jul 08 12:36:25 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892524, encodeId=69038925242c, content=写了篇蛛血预后指标的第二天就被拒了，说不符合他们期刊内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200926/f3a044b4994440679e9fbd0eb436f1c4/4f700d5927e040d591dc11f22ed068df.jpg, createdBy=88fa5263090, createdName=Timky, createdTime=Fri Oct 16 19:31:19 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217586, encodeId=296f121e586d5, content=投了一个月了还是外审，感觉慢多了？有最近投的战友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Sat May 07 11:24:53 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060833, encodeId=e0c1106083332, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：临床研究;脑血管疾病 经验分享：Sep 09, 2021 投稿，2周给回意见小修，2周修回，Oct 13, 2021接受，神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Fri Oct 15 19:49:12 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571817, encodeId=39005e181781, content=审稿速度:1.0 经验分享：脑卒中病例对照研究。5.21 开始under review，6.2收到拒稿通知，只有一个审稿人，认为样本量太少，关联存在偶然性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ee72530812, createdName=124ff737m56(暂无昵称), createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526443, encodeId=f4ab52644379, content=请问这个杂志接受脑血管病的实验文章不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac31694476, createdName=1de67449m99(暂无匿称), createdTime=Mon Aug 29 00:54:00 CST 2016, time=2016-08-29, status=1, ipAttribution=)]

2019-06-03 124ff737m56(暂无昵称)

审稿速度:1.0
经验分享：脑卒中病例对照研究。5.21 开始under review，6.2收到拒稿通知，只有一个审稿人，认为样本量太少，关联存在偶然性。

263 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=587043, encodeId=df1258e043bd, content=1月22投的，到3.19，两个月了还是under review，感觉比评论里慢好多哦，好怕被拒，有点慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVwJ30cBicvMqfUQVv9NaGZ57cSJmOTJIHzcF8iblnZf0icHcNF3aCLbS7vdlliaaibTeUyLiaQjyEuoiaQ/132, createdBy=695d5262554, createdName=樱花7802, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945566, encodeId=fe559455660d, content=请问投这个杂志meta分析，文章类型选什么啊，我在官网投稿看到Review Article(invitation only)是不是只有被邀请，才能投meta分析, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92992475559, createdName=1244896bm50暂无昵称, createdTime=Thu Mar 04 22:55:44 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096343, encodeId=b3f82096343d1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑血管疾病 经验分享：正在准备下一篇文章，再次用到这个系统决定写点经验回馈大家。临床小硕，一篇脑血管方面的文章。一审40天，审稿意见中肯严谨；按审稿意见修改15天后修回，20天后accept，差不多两个半月后online。研究生的第一篇文章，可以选择非OA不要版面费，现影响因子见长，目前2.667。加油吧医学僧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/d6e0b113f3f375444106bd57c5f62af3.jpg, createdBy=03155285285, createdName=V哈哈静, createdTime=Wed Oct 26 21:26:04 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147962, encodeId=fd48214e9626d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中;康复 经验分享：我师兄是雪落的誓言哈哈哈，我跟着他投的期刊。具体时间线：5月31日提交。6月02日 With Editor。6月05日 Under Review（邀请3，接受评审2）。6月26日RRC。6月26日 Major Revise（6条意见）。 7月07日提交修订，7月09日 With Editor，7月11日 Under Review（邀请1，接受评审1）。7月13日RRC。7月14日 Accept。一定要按照修改意见一条一条修改！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75f78245022, createdName=ms6000000472127135, createdTime=Fri Jul 14 08:24:54 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1231312, encodeId=f26612313122e, content=偏重的研究方向：房颤;心血管 经验分享：投稿后With Editor 4天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220708/c81f7dd923c54b8e84fe4716ff9fb706/a82b7266897b4d8c993cc7394b5d6767.jpg, createdBy=80462347615, createdName=122a44d6m85(暂无昵称), createdTime=Fri Jul 08 12:36:25 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892524, encodeId=69038925242c, content=写了篇蛛血预后指标的第二天就被拒了，说不符合他们期刊内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200926/f3a044b4994440679e9fbd0eb436f1c4/4f700d5927e040d591dc11f22ed068df.jpg, createdBy=88fa5263090, createdName=Timky, createdTime=Fri Oct 16 19:31:19 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217586, encodeId=296f121e586d5, content=投了一个月了还是外审，感觉慢多了？有最近投的战友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Sat May 07 11:24:53 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060833, encodeId=e0c1106083332, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：临床研究;脑血管疾病 经验分享：Sep 09, 2021 投稿，2周给回意见小修，2周修回，Oct 13, 2021接受，神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Fri Oct 15 19:49:12 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571817, encodeId=39005e181781, content=审稿速度:1.0 经验分享：脑卒中病例对照研究。5.21 开始under review，6.2收到拒稿通知，只有一个审稿人，认为样本量太少，关联存在偶然性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ee72530812, createdName=124ff737m56(暂无昵称), createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526443, encodeId=f4ab52644379, content=请问这个杂志接受脑血管病的实验文章不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac31694476, createdName=1de67449m99(暂无匿称), createdTime=Mon Aug 29 00:54:00 CST 2016, time=2016-08-29, status=1, ipAttribution=)]

2016-08-29 1de67449m99(暂无匿称)

请问这个杂志接受脑血管病的实验文章不？

250 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务